MICROLIFE AFIB ADVANCED EASY (home use)

- detection of atrial fibrillation (a specific cardiac arrhythmia) with a single measurement
- ISO and EHS protocols, and for “special patients” such as diabetics, elderly people, people with obesity, hypotensive patients and pregnant women
- clinically tested (BHS protocol)
- MAM technology (automatic triple measurement) - 1 data memory
- light indicators
- low battery indicator
- power socket
- equipped with the latest technologies
- medically reliable measurements with AFIB and MAM
- the special deflation valve enables detection of heartbeats down to 30 bpm (for bradycardic patients)

Supplied with a carry case, preformed conical cuff 22-42 cm and instructions (GB, IT, FR, DE).

Measurement range: 20-280 mmHg (pressure), 30-200 beats/minute (pulse)
Dimensions: 160x80x32 mm
Weight: 298 g, including batteries

1 piece.

Microlife AFIB technology.
An innovative, patented technology for the early diagnosis of atrial fibrillation (AF).
More than 30000 strokes can be prevented within the European Union by using Microlife AFIB Technology in primary care.
The new Microlife AFIB technology enables simultaneous blood pressure measurement and screening for atrial fibrillation.
Microlife AFIB Technology detects atrial fibrillation with high sensitivity (97-100%) and specificity (89%), as demonstrated in several clinical studies.
The NICE guidelines on “The diagnosis and assessment of hypertension” recommend the use of AFIB screening during routine blood pressure measurement by general practitioners.
Screening for atrial fibrillation is recommended for patients at home while monitoring blood pressure.